Literature DB >> 25319436

Identification of asthma phenotypes in a tertiary care medical center.

James L Kuhlen1, Amy E Wahlquist, Paul J Nietert, Sonia N Bains.   

Abstract

BACKGROUND: Asthma affects 5% to 10% of the population and its severity is assessed using 4 parameters: lung function, symptom frequency, rescue inhaler use, and number of asthma exacerbations. Asthma is increasingly recognized as a clinical syndrome rather than a single disease. However, the current classification system fails to reflect the heterogeneous characteristics of the disease.
METHODS: A retrospective chart review of 139 patients with mild, moderate, and severe persistent asthma was performed. Variables including baseline and maximal forced expiratory volume over first second (percent predicted), and age of asthma onset were used to classify patients.
RESULTS: This yielded 5 clusters similar to Severe Asthma Research Program (SARP). Subjects in cluster 1 (n = 32) and cluster 2 (n = 47) had early-onset atopic asthma and reduced lung function but differed in medication requirement and health care utilization. Cluster 3 (n = 32) consisted of older obese women with late-onset asthma, less atopy, and mildly reduced forced expiratory volume over first second. Members of cluster 4 (n = 20) and cluster 5 (n = 8) had atopic asthma with severe obstruction but differed in bronchodilator response, age of onset, and oral corticosteroid use. Compared with SARP, our subjects were older, had a higher percentage of African Americans and obesity, and less severe asthma (P < 0.05). The observed clusters differed from SARP clusters in the following: (1) more frequent asthma exacerbations and medication use among cluster 1 and cluster 2; (2) lower medication use in cluster 3 and cluster 4; (3) although total health care utilization was similar, there were fewer emergency department visits in cluster 3 (P < 0.05).
CONCLUSIONS: The SARP algorithm may be used to classify diverse asthmatic populations into a clinically reproducible phenotypic cluster.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25319436      PMCID: PMC4482360          DOI: 10.1097/MAJ.0000000000000346

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  16 in total

1.  Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Pro.

Authors:  Paul M O'Byrne
Journal:  Am J Respir Crit Care Med       Date:  2005-08-15       Impact factor: 21.405

2.  Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction.

Authors:  Marta Kaminska; Susan Foley; Karim Maghni; Claudine Storness-Bliss; Harvey Coxson; Heberto Ghezzo; Catherine Lemière; Ronald Olivenstein; Pierre Ernst; Qutayba Hamid; James Martin
Journal:  J Allergy Clin Immunol       Date:  2009-05-29       Impact factor: 10.793

3.  Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.

Authors:  Stanley J Szefler; Herman Mitchell; Christine A Sorkness; Peter J Gergen; George T O'Connor; Wayne J Morgan; Meyer Kattan; Jacqueline A Pongracic; Stephen J Teach; Gordon R Bloomberg; Peyton A Eggleston; Rebecca S Gruchalla; Carolyn M Kercsmar; Andrew H Liu; Jeremy J Wildfire; Matthew D Curry; William W Busse
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

4.  Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

Authors:  Nicola A Hanania; Oral Alpan; Daniel L Hamilos; John J Condemi; Irmarie Reyes-Rivera; Jin Zhu; Karin E Rosen; Mark D Eisner; Dennis A Wong; William Busse
Journal:  Ann Intern Med       Date:  2011-05-03       Impact factor: 25.391

5.  Hospitalizations for asthma in children are linked to undertreatment and insufficient asthma education.

Authors:  Claire Fuhrman; Jean-Christophe Dubus; Christophe Marguet; Christophe Delacourt; Caroline Thumerelle; Jacques de Blic; Marie-Christine Delmas
Journal:  J Asthma       Date:  2011-05-20       Impact factor: 2.515

6.  Asthma in older patients: factors associated with hospitalization.

Authors:  Gregory B Diette; Jerry A Krishnan; Francesca Dominici; Ed Haponik; Elizabeth Ann Skinner; Donald Steinwachs; Albert W Wu
Journal:  Arch Intern Med       Date:  2002-05-27

7.  Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

8.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

9.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.

Authors:  Wendy C Moore; Deborah A Meyers; Sally E Wenzel; W Gerald Teague; Huashi Li; Xingnan Li; Ralph D'Agostino; Mario Castro; Douglas Curran-Everett; Anne M Fitzpatrick; Benjamin Gaston; Nizar N Jarjour; Ronald Sorkness; William J Calhoun; Kian Fan Chung; Suzy A A Comhair; Raed A Dweik; Elliot Israel; Stephen P Peters; William W Busse; Serpil C Erzurum; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2009-11-05       Impact factor: 21.405

10.  Cluster analysis and clinical asthma phenotypes.

Authors:  Pranab Haldar; Ian D Pavord; Ruth H Green; Dominic E Shaw; Michael A Berry; Michael Thomas; Christopher E Brightling; Andrew J Wardlaw
Journal:  Am J Respir Crit Care Med       Date:  2008-05-14       Impact factor: 21.405

View more
  8 in total

Review 1.  Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment?

Authors:  Anne M Fitzpatrick; Wendy C Moore
Journal:  J Allergy Clin Immunol Pract       Date:  2017 Jul - Aug

Review 2.  Phenotype-Driven Therapeutics in Severe Asthma.

Authors:  Maria Theresa D Opina; Wendy C Moore
Journal:  Curr Allergy Asthma Rep       Date:  2017-02       Impact factor: 4.806

Review 3.  Severe Asthma in Children: Lessons Learned and Future Directions.

Authors:  Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jan-Feb

4.  Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells.

Authors:  Elena Alexandrova; Giovanni Nassa; Giacomo Corleone; Anton Buzdin; Alexander M Aliper; Nadezhda Terekhanova; Denis Shepelin; Alexander Zhavoronkov; Michael Tamm; Luciano Milanesi; Nicola Miglino; Alessandro Weisz; Pieter Borger
Journal:  Oncotarget       Date:  2016-05-03

Review 5.  Asthma heterogeneity and severity.

Authors:  Tara F Carr; Eugene Bleecker
Journal:  World Allergy Organ J       Date:  2016-11-29       Impact factor: 4.084

6.  Subtypes of asthma based on asthma control and severity: a latent class analysis.

Authors:  Elina M S Mäkikyrö; Maritta S Jaakkola; Jouni J K Jaakkola
Journal:  Respir Res       Date:  2017-01-23

7.  Prevalence and Geographic Distribution Pattern of Asthma in Tehran by ECRHS.

Authors:  Hooman Sharifi; Mostafa Ghanei; Makan Sadr; Habib Emami; Atefeh Fakharian; Zahra Hessami; Mahshid Aryanpur; Hamidreza Jamaati; Mohammad Reza Masjedi
Journal:  Tanaffos       Date:  2016

Review 8.  Significantly Higher Prevalence Rate of Asthma and Bipolar Disorder Co-Morbidity: A Meta-Analysis and Review Under PRISMA Guidelines.

Authors:  Ming-Kung Wu; Hung-Yu Wang; Yen-Wen Chen; Pao-Yen Lin; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.